MIM
CTS icon

MetLife Investment Management’s CTS Corp CTS Stock Holding History

MetLife Investment Management’s Portfolio CTS Stock Details CTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$794K Buy
16,635
+438
+3% +$22K ﹤0.01% 1510
2025
Q4 		$694K Sell
16,197
-1,903
-11% -$79.8K ﹤0.01% 1631
2025
Q3 		$723K Hold
18,100
– – ﹤0.01% 1635
2025
Q2 		$771K Hold
18,100
– – ﹤0.01% 1452
2025
Q1 		$752K Sell
18,100
-278
-2% -$13K ﹤0.01% 1505
2024
Q4 		$969K Buy
18,378
+1,339
+8% +$70.1K 0.01% 1431
2024
Q3 		$824K Sell
17,039
-888
-5% -$43.1K ﹤0.01% 1499
2024
Q2 		$908K Buy
17,927
+1,686
+10% +$83.3K 0.01% 1393
2024
Q1 		$760K Hold
16,241
– – 0.01% 1452
2023
Q4 		$710K Hold
16,241
– – 0.01% 1492
2023
Q3 		$678K Hold
16,241
– – 0.01% 1449
2023
Q2 		$692K Hold
16,241
– – 0.01% 1482
2023
Q1 		$803K Hold
16,241
– – 0.01% 1349
2022
Q4 		$640K Sell
16,241
-576
-3% -$23.7K ﹤0.01% 1485
2022
Q3 		$700K Buy
16,817
+956
+6% +$38.4K 0.01% 1397
2022
Q2 		$540K Sell
15,861
-1,029
-6% -$37.3K ﹤0.01% 1601
2022
Q1 		$597K Buy
16,890
+4,539
+37% +$159K ﹤0.01% 1663
2021
Q4 		$454K Hold
12,351
– – ﹤0.01% 1560
2021
Q3 		$382K Hold
12,351
– – ﹤0.01% 1688
2021
Q2 		$459K Hold
12,351
– – ﹤0.01% 1620
2021
Q1 		$384K Hold
12,351
– – ﹤0.01% 1675
2020
Q4 		$424K Sell
12,351
-3,350
-21% -$99.1K ﹤0.01% 1567
2020
Q3 		$346K Hold
15,701
– – ﹤0.01% 1558
2020
Q2 		$315K Hold
15,701
– – ﹤0.01% 1628
2020
Q1 		$391K Hold
15,701
– – 0.01% 1339
2019
Q4 		$471K Hold
15,701
– – ﹤0.01% 1496
2019
Q3 		$508K Hold
15,701
– – 0.01% 1410
2019
Q2 		$433K Hold
15,701
– – ﹤0.01% 1570
2019
Q1 		$461K Hold
15,701
– – 0.01% 1501
2018
Q4 		$406K Hold
15,701
– – ﹤0.01% 1497
2018
Q3 		$539K Hold
15,701
– – 0.01% 1494
2018
Q2 		$565K Hold
15,701
– – 0.01% 1335
2018
Q1 		$427K Hold
15,701
– – 0.01% 1461
2017
Q4 		$404K Buy
+15,701
New +$413K ﹤0.01% 1524

Other funds holding CTS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

MetLife Investment Management's CTS Position: Q1 2026 in Review

MetLife Investment Management increased its CTS Corp (CTS) stake by 2.7% in Q1 2026, buying an estimated $22K and bringing the position to 16,635 shares worth $794K. The position accounts for ﹤0.01% of the portfolio, ranked #1510.

MetLife Investment Management first reported a position in CTS in Q4 2017 and has held it in 34 quarters since. The position peaked at $969K in Q4 2024. 243 funds tracked by Wall St. Rank hold CTS as of Q1 2026.

  • MetLife Investment Management held 16,635 shares of CTS Corp worth $794K as of Q1 2026.
  • MetLife Investment Management bought 438 CTS Corp shares in Q1 2026, an estimated $22K.
  • CTS Corp made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1510 holding.
  • MetLife Investment Management first reported a position in CTS Corp in Q4 2017 and has held it in 34 quarters since.
  • MetLife Investment Management's CTS Corp position peaked at $969K in Q4 2024.
  • 243 funds tracked by Wall St. Rank held CTS Corp as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.